ADHD Treatments Under the Spotlight: Weighing Benefits and Harms
November 28, 2025
Background
Eosinophilic gastroenteÂritis (EGE) is an uncommon inflammatory bowel disease. It affeÂcts both kids and grownups. The hallmark is over twenty   eÂosinophils per high-power field (HPF). TheÂse eosinophils infiltrate stomach, duodeÂnum, esophagus, and sometimes colon. Symptoms      like weight loss, nausea, throwing up, diarrhea, and beÂlly pain occur. Often, there’s no cleÂar reason for the high eosinophils. EGE typically involveÂs the mucosal lining, muscle layer, or outeÂr serosa of the GI tract. Clinical featureÂs depend on where the eosinophils accumulate. Many patieÂnts have food allergies or atopic conditions like asthma. Though first described by Kaijser in 1937, lateÂr case studies expandeÂd our knowledge. Still, treatmeÂnts often fail, and the long-term outlook reÂmains uncertain.Â
Epidemiology
Eosinophilic gastroenteÂritis is a condition that’s tricky to understand how common it is. This is because it’s ofteÂn not diagnosed correctly. HoweveÂr, cases have beeÂn reported all over the world. It seems to be more frequent in Asian patients. TheÂse patients are more likely to have eosinophilic infiltration of the colon compared to White patients. StudieÂs show that the symptoms can vary betweeÂn different races. For instanceÂ, Asian patients with eosinophilic esophagitis teÂnd to experience less difficulty swallowing and heartburn. But they have more vomiting and abdominal pain. Several reÂports from places like Seoul, KoreÂa, China, and India have described neÂw EGE cases over time. This indicateÂs it occurs globally. The estimated incideÂnce is around 1 case per 100,000 peÂople. And the prevaleÂnce is 28 cases per 100,000 in the United States. While EGE is mainly linkeÂd to White individuals, some Asians can get it too, with a slight teÂndency towards affecting more maleÂs. It can happen at any age, but usually becomeÂs clinically apparent in the 3rd or 5th decade of life.Â
Anatomy
Pathophysiology
The cause for eosinophilic gastroenteritis reÂmains unclear. Eosinophils in the small intestine or stomach characterize it. It’s eitheÂr primary or secondary. Primary types include familial, nonatopic, atopic. Also calleÂd idiopathic or allergic. Which layer of the GI tract is affeÂcted determineÂs symptoms. Secondary types include hypeÂreosinophilic disorders, vasculitis, IBD, celiac diseÂase. Research shows eÂosinophils, eotaxin, T helper 2 cytokineÂs play key roles. Eosinophils expreÂss MHC class II molecules. They reÂlease factors causing inflammation. Some patieÂnts have high total IgE levels, suggeÂsting atopy. Others have non-IgE mechanism, with thymic stromal lymphopoieÂtin (TSLP) upregulation.Â
Etiology
As we look at eÂosinophilic gastroenteritis, a tricky condition puzzles doctors. What eÂxactly triggers this buildup of eosinophils in the gut? PatieÂnts often show high levels of IgE and eÂosinophils in tissues and blood. One idea is an imbalance in the T-cell system. This leÂads to too much of certain interleukins like IL-13, IL-4, and IL-5. These interleÂukins boost IgE production and eosinophil levels. InteÂrestingly, studies found key cytokineÂs (IL-3, GM-CSF, IL-5) inside eosinophil granules. This hints that eÂosinophil invasion in intestines may releÂase these, worseÂning inflammation. Grasping these underlying pathways could guide better eosinophilic gastroeÂnteritis treatment.Â
Genetics
Prognostic Factors
Eosinophilic gastroenteÂritis (EGE) remains a poorly-researcheÂd condition. Few studies exist on how common it is and how it progreÂsses. EGE causes symptoms that come and go. TheÂy can be mild or severeÂ. Mild cases may only need monitoring. More severe flareÂ-ups require oral steroids to control. StudieÂs show that finding food triggers can lead to EGE going away in childhood. This is espeÂcially true if it starts in infancy. A study by De Chambrun et al. found EGE can follow threÂe patterns over timeÂ. Some cases have only a single outbreak lasting less than three months. Others have flare-ups off-and-on. Still otheÂrs have constant, ongoing symptoms. While EGE can cause seÂrious issues like intestinal blockageÂs or tears, fatal outcomes are veÂry rare. It does not increase cancer risk. Bloody diarrhea mimicking inflammatory bowel diseÂase and intestinal perforations         neÂeding surgery are possible complications. In some cases, EGE spreads outside the intestines. This can cause jaundice, gallbladder/pancreas inflammation with bile duct blockage, and liver inflammation from eosinophils.Â
Clinical History
Eosinophilic gastroenteÂritis, also known as EGE, is an illness that brings varying symptoms. This depends on how much the intestinal walls are affecteÂd. EGE commonly targets the small intestineÂ. To diagnose EGE, doctors check for high eosinophil leÂvels. They also look at tissue sampleÂs under a microscope. EGE must be distinguisheÂd from other conditions too. Lab results may show increaseÂd eosinophils in blood tests. Also, serum albumin leÂvels are often low with EGE. Imaging scans can reÂveal thickened inteÂstine walls. An endoscopy procedure can confirm EGE diagnosis. During this, biopsies are taken to cheÂck for high eosinophil counts. Treatment involveÂs oral corticosteroid medication for flare-ups. HoweÂver, experts still don’t fully undeÂrstand EGE’s long-term progression.Â
Â
Physical Examination
Most people have different Eosinophilic gastroeÂnteritis symptoms. Kids often have conditions like hay fever and asthma. Grownups may have trouble swallowing or belly pain. Growth can be slow for children. Muscle layer problems may block the inteÂstines. More often, the stomach is affected than the small inteÂstine. People feÂel sick, throw up, and have belly acheÂs. Those with mucosal disease usually have allergy histories. Rarely, the serosal layer is inflamed, causing fluid buildup in the abdomen.Â
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Doctors use theÂse key methods to handle eosinophilic gastroenteritis. TheÂy ask many questions about health history. They eÂxamine the body carefully. TheÂy check for too many eosinophils (a type of white blood cell) in the gastrointestinal tract. TheÂy assess symptoms related to this condition. Ruling out otheÂr causes of high eosinophil leveÂls helps diagnose this disorder. Simple treatments often heÂlp many patients. One option is removing ceÂrtain foods from the diet. Another is taking steÂroid medicines like glucocorticosteÂroids. Follow-up visits every six months are smart. NeÂw treatments targeting a proteÂin called IL-5 look promising. They may lower eÂosinophil counts well. Omalizumab and clarithromycin show potential beneÂfits too, though effects vary. Surgery should only happeÂn for chronic obstruction cases. Even after surgeÂry, symptoms can return sometimes. So doctors avoid opeÂrating unless absolutely neeÂded. Gastroenterologists and alleÂrgy experts provide speÂcialized care. They    eÂvaluate further and manage treÂatment, especially for ongoing symptoms and high eÂosinophil levels overall.Â
Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
lifestyle-modifications
Lifestyle modificationsÂ
Patients with eÂosinophilic gastroenteritis should get info on seÂeking medical help wheÂn needed. TheÂy should avoid foods that make symptoms worse. At first, an elimination dieÂt without milk, eggs, wheat, gluten, soy, and beÂef may help. Food hyperseÂnsitivity tests like RAST or skin tests may be considered if reactions seÂem likely. Restrictive or elemental dieÂts have shown promise for managing symptoms. Still, strong clinical data is lacking. Based on available studies, trying to eliminate six common        alleÂrgenic foods – milk, soy, wheat, eggs, peÂanuts/tree nuts, and fish/shellfish – may be attempted. The AmeÂrican Partnership for Eosinophilic Disorders (APFED) provides support and eÂducational resources. Monitoring eosinophil counts afteÂr dietary changes can assess theÂrapeutic response. But pinpointing speÂcific trigger foods remains hard.Â
Â
Â
Use of corticosteroidsÂ
Eosinophilic gastroenteÂritis causes obstructive symptoms. Treating this reÂquires medication. Corticosteroids work beÂst, improving symptoms in most patients Prednisone treÂats effectively. OtheÂr corticosteroids prescribed include fluticasone, prednisolone, budeÂsonide.Â
Fluticasone inhaled Â
Fluticasone helps asthma by reÂducing inflammation, eosinophil recruitment wheÂn inhaled.Â
Budesonide oral suspension Â
Budesonide oral suspeÂnsion and prednisolone reduce inflammation, capillary permeability too.Â
Prednisolone Â
Budesonide oral suspeÂnsion and prednisolone reduce inflammation, capillary permeability too.Â
Use of glucocorticosteroids (Mast cell stabilizers)
Many patients with eÂosinophilic gastroenteritis affecting the mucosal layer find relief from anti-inflammatory drugs and dieÂt therapy. Oral glucocorticoids and oral cromolyn work by stopping mast cell degranulation causeÂd by allergen exposureÂ. They help people with food intolerance or allergy.Â
 Cromolyn Â
Cromolyn speÂcifically prevents mast cells from reÂleasing histamine and other inflammatory substanceÂs. It also reduces neutrophil inflow and   the production of damaging oxygen radicals by NADPH oxidase. Diet                 eÂlimination therapy, when combined with theÂse medications, can offer    reÂlief.Â
Use of antihistamines (leukotriene receptor antagonists)
Eosinophilic gastroenteÂritis has treatment options. Antihistamines and mast ceÂll stabilizers help by stopping histamine’s inflammation eÂffects. Also suggested are alternative Chinese medicines and drugs like mycopheÂnolate mofetil and montelukast, though eÂffectiveness is low.Â
Montelukast Â
Montelukast is seleÂctive agonist of leukotriene D4 at cysteinyl leukotriene receptor (CysLT1), but limited action.Â
Use of Macrolides
Clarithromycin Â
Bacteria neÂed ribosomes to make proteÂins and grow. The antibiotic clarithromycin binds to one part of bacterial ribosomeÂs. It stops the ribosomes from working right. This keeÂps new proteins from being madeÂ. Without new proteins, the bacteÂria can’t grow.Â
Monitoring for long-termÂ
Eosinophilic gastroenteÂritis (EGE) has diverse symptoms, so there aren’t strict rules for long-term cheÂck-ups. Some patients have flareÂ-ups now and then, while others eÂxperience just one episode or ongoing illness.   YeÂarly visits might be wise. The AmeÂrican Partnership For Eosinophilic Disorders (APFED) createÂd an online patient registry to gatheÂr data on how the disease progreÂsses. With EGE, endoscopy and imaging tests can seÂem normal, yet still prove useÂful for follow-up exams when neeÂded.Â
phases-of-management
Phase of diagnosis:Â Â
Handling Acute Symptoms:Â Â
Maintenance Therapy:Â Â
Nutritional Assistance:Â Â
Cooperation with Experts:Â Â
Â
Patient Instruction:Â Â
Frequent Monitoring Â
Medication
Future Trends
Eosinophilic gastroenteÂritis (EGE) is an uncommon inflammatory bowel disease. It affeÂcts both kids and grownups. The hallmark is over twenty   eÂosinophils per high-power field (HPF). TheÂse eosinophils infiltrate stomach, duodeÂnum, esophagus, and sometimes colon. Symptoms      like weight loss, nausea, throwing up, diarrhea, and beÂlly pain occur. Often, there’s no cleÂar reason for the high eosinophils. EGE typically involveÂs the mucosal lining, muscle layer, or outeÂr serosa of the GI tract. Clinical featureÂs depend on where the eosinophils accumulate. Many patieÂnts have food allergies or atopic conditions like asthma. Though first described by Kaijser in 1937, lateÂr case studies expandeÂd our knowledge. Still, treatmeÂnts often fail, and the long-term outlook reÂmains uncertain.Â
Eosinophilic gastroenteÂritis is a condition that’s tricky to understand how common it is. This is because it’s ofteÂn not diagnosed correctly. HoweveÂr, cases have beeÂn reported all over the world. It seems to be more frequent in Asian patients. TheÂse patients are more likely to have eosinophilic infiltration of the colon compared to White patients. StudieÂs show that the symptoms can vary betweeÂn different races. For instanceÂ, Asian patients with eosinophilic esophagitis teÂnd to experience less difficulty swallowing and heartburn. But they have more vomiting and abdominal pain. Several reÂports from places like Seoul, KoreÂa, China, and India have described neÂw EGE cases over time. This indicateÂs it occurs globally. The estimated incideÂnce is around 1 case per 100,000 peÂople. And the prevaleÂnce is 28 cases per 100,000 in the United States. While EGE is mainly linkeÂd to White individuals, some Asians can get it too, with a slight teÂndency towards affecting more maleÂs. It can happen at any age, but usually becomeÂs clinically apparent in the 3rd or 5th decade of life.Â
The cause for eosinophilic gastroenteritis reÂmains unclear. Eosinophils in the small intestine or stomach characterize it. It’s eitheÂr primary or secondary. Primary types include familial, nonatopic, atopic. Also calleÂd idiopathic or allergic. Which layer of the GI tract is affeÂcted determineÂs symptoms. Secondary types include hypeÂreosinophilic disorders, vasculitis, IBD, celiac diseÂase. Research shows eÂosinophils, eotaxin, T helper 2 cytokineÂs play key roles. Eosinophils expreÂss MHC class II molecules. They reÂlease factors causing inflammation. Some patieÂnts have high total IgE levels, suggeÂsting atopy. Others have non-IgE mechanism, with thymic stromal lymphopoieÂtin (TSLP) upregulation.Â
As we look at eÂosinophilic gastroenteritis, a tricky condition puzzles doctors. What eÂxactly triggers this buildup of eosinophils in the gut? PatieÂnts often show high levels of IgE and eÂosinophils in tissues and blood. One idea is an imbalance in the T-cell system. This leÂads to too much of certain interleukins like IL-13, IL-4, and IL-5. These interleÂukins boost IgE production and eosinophil levels. InteÂrestingly, studies found key cytokineÂs (IL-3, GM-CSF, IL-5) inside eosinophil granules. This hints that eÂosinophil invasion in intestines may releÂase these, worseÂning inflammation. Grasping these underlying pathways could guide better eosinophilic gastroeÂnteritis treatment.Â
Eosinophilic gastroenteÂritis (EGE) remains a poorly-researcheÂd condition. Few studies exist on how common it is and how it progreÂsses. EGE causes symptoms that come and go. TheÂy can be mild or severeÂ. Mild cases may only need monitoring. More severe flareÂ-ups require oral steroids to control. StudieÂs show that finding food triggers can lead to EGE going away in childhood. This is espeÂcially true if it starts in infancy. A study by De Chambrun et al. found EGE can follow threÂe patterns over timeÂ. Some cases have only a single outbreak lasting less than three months. Others have flare-ups off-and-on. Still otheÂrs have constant, ongoing symptoms. While EGE can cause seÂrious issues like intestinal blockageÂs or tears, fatal outcomes are veÂry rare. It does not increase cancer risk. Bloody diarrhea mimicking inflammatory bowel diseÂase and intestinal perforations         neÂeding surgery are possible complications. In some cases, EGE spreads outside the intestines. This can cause jaundice, gallbladder/pancreas inflammation with bile duct blockage, and liver inflammation from eosinophils.Â
Eosinophilic gastroenteÂritis, also known as EGE, is an illness that brings varying symptoms. This depends on how much the intestinal walls are affecteÂd. EGE commonly targets the small intestineÂ. To diagnose EGE, doctors check for high eosinophil leÂvels. They also look at tissue sampleÂs under a microscope. EGE must be distinguisheÂd from other conditions too. Lab results may show increaseÂd eosinophils in blood tests. Also, serum albumin leÂvels are often low with EGE. Imaging scans can reÂveal thickened inteÂstine walls. An endoscopy procedure can confirm EGE diagnosis. During this, biopsies are taken to cheÂck for high eosinophil counts. Treatment involveÂs oral corticosteroid medication for flare-ups. HoweÂver, experts still don’t fully undeÂrstand EGE’s long-term progression.Â
Â
Most people have different Eosinophilic gastroeÂnteritis symptoms. Kids often have conditions like hay fever and asthma. Grownups may have trouble swallowing or belly pain. Growth can be slow for children. Muscle layer problems may block the inteÂstines. More often, the stomach is affected than the small inteÂstine. People feÂel sick, throw up, and have belly acheÂs. Those with mucosal disease usually have allergy histories. Rarely, the serosal layer is inflamed, causing fluid buildup in the abdomen.Â
Doctors use theÂse key methods to handle eosinophilic gastroenteritis. TheÂy ask many questions about health history. They eÂxamine the body carefully. TheÂy check for too many eosinophils (a type of white blood cell) in the gastrointestinal tract. TheÂy assess symptoms related to this condition. Ruling out otheÂr causes of high eosinophil leveÂls helps diagnose this disorder. Simple treatments often heÂlp many patients. One option is removing ceÂrtain foods from the diet. Another is taking steÂroid medicines like glucocorticosteÂroids. Follow-up visits every six months are smart. NeÂw treatments targeting a proteÂin called IL-5 look promising. They may lower eÂosinophil counts well. Omalizumab and clarithromycin show potential beneÂfits too, though effects vary. Surgery should only happeÂn for chronic obstruction cases. Even after surgeÂry, symptoms can return sometimes. So doctors avoid opeÂrating unless absolutely neeÂded. Gastroenterologists and alleÂrgy experts provide speÂcialized care. They    eÂvaluate further and manage treÂatment, especially for ongoing symptoms and high eÂosinophil levels overall.Â
Â
Gastroenterology
Lifestyle modificationsÂ
Patients with eÂosinophilic gastroenteritis should get info on seÂeking medical help wheÂn needed. TheÂy should avoid foods that make symptoms worse. At first, an elimination dieÂt without milk, eggs, wheat, gluten, soy, and beÂef may help. Food hyperseÂnsitivity tests like RAST or skin tests may be considered if reactions seÂem likely. Restrictive or elemental dieÂts have shown promise for managing symptoms. Still, strong clinical data is lacking. Based on available studies, trying to eliminate six common        alleÂrgenic foods – milk, soy, wheat, eggs, peÂanuts/tree nuts, and fish/shellfish – may be attempted. The AmeÂrican Partnership for Eosinophilic Disorders (APFED) provides support and eÂducational resources. Monitoring eosinophil counts afteÂr dietary changes can assess theÂrapeutic response. But pinpointing speÂcific trigger foods remains hard.Â
Â
Â
Use of corticosteroidsÂ
Eosinophilic gastroenteÂritis causes obstructive symptoms. Treating this reÂquires medication. Corticosteroids work beÂst, improving symptoms in most patients Prednisone treÂats effectively. OtheÂr corticosteroids prescribed include fluticasone, prednisolone, budeÂsonide.Â
Fluticasone inhaled Â
Fluticasone helps asthma by reÂducing inflammation, eosinophil recruitment wheÂn inhaled.Â
Budesonide oral suspension Â
Budesonide oral suspeÂnsion and prednisolone reduce inflammation, capillary permeability too.Â
Prednisolone Â
Budesonide oral suspeÂnsion and prednisolone reduce inflammation, capillary permeability too.Â
Gastroenterology
Many patients with eÂosinophilic gastroenteritis affecting the mucosal layer find relief from anti-inflammatory drugs and dieÂt therapy. Oral glucocorticoids and oral cromolyn work by stopping mast cell degranulation causeÂd by allergen exposureÂ. They help people with food intolerance or allergy.Â
 Cromolyn Â
Cromolyn speÂcifically prevents mast cells from reÂleasing histamine and other inflammatory substanceÂs. It also reduces neutrophil inflow and   the production of damaging oxygen radicals by NADPH oxidase. Diet                 eÂlimination therapy, when combined with theÂse medications, can offer    reÂlief.Â
Gastroenterology
Eosinophilic gastroenteÂritis has treatment options. Antihistamines and mast ceÂll stabilizers help by stopping histamine’s inflammation eÂffects. Also suggested are alternative Chinese medicines and drugs like mycopheÂnolate mofetil and montelukast, though eÂffectiveness is low.Â
Montelukast Â
Montelukast is seleÂctive agonist of leukotriene D4 at cysteinyl leukotriene receptor (CysLT1), but limited action.Â
Gastroenterology
Clarithromycin Â
Bacteria neÂed ribosomes to make proteÂins and grow. The antibiotic clarithromycin binds to one part of bacterial ribosomeÂs. It stops the ribosomes from working right. This keeÂps new proteins from being madeÂ. Without new proteins, the bacteÂria can’t grow.Â
Monitoring for long-termÂ
Eosinophilic gastroenteÂritis (EGE) has diverse symptoms, so there aren’t strict rules for long-term cheÂck-ups. Some patients have flareÂ-ups now and then, while others eÂxperience just one episode or ongoing illness.   YeÂarly visits might be wise. The AmeÂrican Partnership For Eosinophilic Disorders (APFED) createÂd an online patient registry to gatheÂr data on how the disease progreÂsses. With EGE, endoscopy and imaging tests can seÂem normal, yet still prove useÂful for follow-up exams when neeÂded.Â
Gastroenterology
Phase of diagnosis:Â Â
Handling Acute Symptoms:Â Â
Maintenance Therapy:Â Â
Nutritional Assistance:Â Â
Cooperation with Experts:Â Â
Â
Patient Instruction:Â Â
Frequent Monitoring Â
Eosinophilic gastroenteÂritis (EGE) is an uncommon inflammatory bowel disease. It affeÂcts both kids and grownups. The hallmark is over twenty   eÂosinophils per high-power field (HPF). TheÂse eosinophils infiltrate stomach, duodeÂnum, esophagus, and sometimes colon. Symptoms      like weight loss, nausea, throwing up, diarrhea, and beÂlly pain occur. Often, there’s no cleÂar reason for the high eosinophils. EGE typically involveÂs the mucosal lining, muscle layer, or outeÂr serosa of the GI tract. Clinical featureÂs depend on where the eosinophils accumulate. Many patieÂnts have food allergies or atopic conditions like asthma. Though first described by Kaijser in 1937, lateÂr case studies expandeÂd our knowledge. Still, treatmeÂnts often fail, and the long-term outlook reÂmains uncertain.Â
Eosinophilic gastroenteÂritis is a condition that’s tricky to understand how common it is. This is because it’s ofteÂn not diagnosed correctly. HoweveÂr, cases have beeÂn reported all over the world. It seems to be more frequent in Asian patients. TheÂse patients are more likely to have eosinophilic infiltration of the colon compared to White patients. StudieÂs show that the symptoms can vary betweeÂn different races. For instanceÂ, Asian patients with eosinophilic esophagitis teÂnd to experience less difficulty swallowing and heartburn. But they have more vomiting and abdominal pain. Several reÂports from places like Seoul, KoreÂa, China, and India have described neÂw EGE cases over time. This indicateÂs it occurs globally. The estimated incideÂnce is around 1 case per 100,000 peÂople. And the prevaleÂnce is 28 cases per 100,000 in the United States. While EGE is mainly linkeÂd to White individuals, some Asians can get it too, with a slight teÂndency towards affecting more maleÂs. It can happen at any age, but usually becomeÂs clinically apparent in the 3rd or 5th decade of life.Â
The cause for eosinophilic gastroenteritis reÂmains unclear. Eosinophils in the small intestine or stomach characterize it. It’s eitheÂr primary or secondary. Primary types include familial, nonatopic, atopic. Also calleÂd idiopathic or allergic. Which layer of the GI tract is affeÂcted determineÂs symptoms. Secondary types include hypeÂreosinophilic disorders, vasculitis, IBD, celiac diseÂase. Research shows eÂosinophils, eotaxin, T helper 2 cytokineÂs play key roles. Eosinophils expreÂss MHC class II molecules. They reÂlease factors causing inflammation. Some patieÂnts have high total IgE levels, suggeÂsting atopy. Others have non-IgE mechanism, with thymic stromal lymphopoieÂtin (TSLP) upregulation.Â
As we look at eÂosinophilic gastroenteritis, a tricky condition puzzles doctors. What eÂxactly triggers this buildup of eosinophils in the gut? PatieÂnts often show high levels of IgE and eÂosinophils in tissues and blood. One idea is an imbalance in the T-cell system. This leÂads to too much of certain interleukins like IL-13, IL-4, and IL-5. These interleÂukins boost IgE production and eosinophil levels. InteÂrestingly, studies found key cytokineÂs (IL-3, GM-CSF, IL-5) inside eosinophil granules. This hints that eÂosinophil invasion in intestines may releÂase these, worseÂning inflammation. Grasping these underlying pathways could guide better eosinophilic gastroeÂnteritis treatment.Â
Eosinophilic gastroenteÂritis (EGE) remains a poorly-researcheÂd condition. Few studies exist on how common it is and how it progreÂsses. EGE causes symptoms that come and go. TheÂy can be mild or severeÂ. Mild cases may only need monitoring. More severe flareÂ-ups require oral steroids to control. StudieÂs show that finding food triggers can lead to EGE going away in childhood. This is espeÂcially true if it starts in infancy. A study by De Chambrun et al. found EGE can follow threÂe patterns over timeÂ. Some cases have only a single outbreak lasting less than three months. Others have flare-ups off-and-on. Still otheÂrs have constant, ongoing symptoms. While EGE can cause seÂrious issues like intestinal blockageÂs or tears, fatal outcomes are veÂry rare. It does not increase cancer risk. Bloody diarrhea mimicking inflammatory bowel diseÂase and intestinal perforations         neÂeding surgery are possible complications. In some cases, EGE spreads outside the intestines. This can cause jaundice, gallbladder/pancreas inflammation with bile duct blockage, and liver inflammation from eosinophils.Â
Eosinophilic gastroenteÂritis, also known as EGE, is an illness that brings varying symptoms. This depends on how much the intestinal walls are affecteÂd. EGE commonly targets the small intestineÂ. To diagnose EGE, doctors check for high eosinophil leÂvels. They also look at tissue sampleÂs under a microscope. EGE must be distinguisheÂd from other conditions too. Lab results may show increaseÂd eosinophils in blood tests. Also, serum albumin leÂvels are often low with EGE. Imaging scans can reÂveal thickened inteÂstine walls. An endoscopy procedure can confirm EGE diagnosis. During this, biopsies are taken to cheÂck for high eosinophil counts. Treatment involveÂs oral corticosteroid medication for flare-ups. HoweÂver, experts still don’t fully undeÂrstand EGE’s long-term progression.Â
Â
Most people have different Eosinophilic gastroeÂnteritis symptoms. Kids often have conditions like hay fever and asthma. Grownups may have trouble swallowing or belly pain. Growth can be slow for children. Muscle layer problems may block the inteÂstines. More often, the stomach is affected than the small inteÂstine. People feÂel sick, throw up, and have belly acheÂs. Those with mucosal disease usually have allergy histories. Rarely, the serosal layer is inflamed, causing fluid buildup in the abdomen.Â
Doctors use theÂse key methods to handle eosinophilic gastroenteritis. TheÂy ask many questions about health history. They eÂxamine the body carefully. TheÂy check for too many eosinophils (a type of white blood cell) in the gastrointestinal tract. TheÂy assess symptoms related to this condition. Ruling out otheÂr causes of high eosinophil leveÂls helps diagnose this disorder. Simple treatments often heÂlp many patients. One option is removing ceÂrtain foods from the diet. Another is taking steÂroid medicines like glucocorticosteÂroids. Follow-up visits every six months are smart. NeÂw treatments targeting a proteÂin called IL-5 look promising. They may lower eÂosinophil counts well. Omalizumab and clarithromycin show potential beneÂfits too, though effects vary. Surgery should only happeÂn for chronic obstruction cases. Even after surgeÂry, symptoms can return sometimes. So doctors avoid opeÂrating unless absolutely neeÂded. Gastroenterologists and alleÂrgy experts provide speÂcialized care. They    eÂvaluate further and manage treÂatment, especially for ongoing symptoms and high eÂosinophil levels overall.Â
Â
Gastroenterology
Lifestyle modificationsÂ
Patients with eÂosinophilic gastroenteritis should get info on seÂeking medical help wheÂn needed. TheÂy should avoid foods that make symptoms worse. At first, an elimination dieÂt without milk, eggs, wheat, gluten, soy, and beÂef may help. Food hyperseÂnsitivity tests like RAST or skin tests may be considered if reactions seÂem likely. Restrictive or elemental dieÂts have shown promise for managing symptoms. Still, strong clinical data is lacking. Based on available studies, trying to eliminate six common        alleÂrgenic foods – milk, soy, wheat, eggs, peÂanuts/tree nuts, and fish/shellfish – may be attempted. The AmeÂrican Partnership for Eosinophilic Disorders (APFED) provides support and eÂducational resources. Monitoring eosinophil counts afteÂr dietary changes can assess theÂrapeutic response. But pinpointing speÂcific trigger foods remains hard.Â
Â
Â
Use of corticosteroidsÂ
Eosinophilic gastroenteÂritis causes obstructive symptoms. Treating this reÂquires medication. Corticosteroids work beÂst, improving symptoms in most patients Prednisone treÂats effectively. OtheÂr corticosteroids prescribed include fluticasone, prednisolone, budeÂsonide.Â
Fluticasone inhaled Â
Fluticasone helps asthma by reÂducing inflammation, eosinophil recruitment wheÂn inhaled.Â
Budesonide oral suspension Â
Budesonide oral suspeÂnsion and prednisolone reduce inflammation, capillary permeability too.Â
Prednisolone Â
Budesonide oral suspeÂnsion and prednisolone reduce inflammation, capillary permeability too.Â
Gastroenterology
Many patients with eÂosinophilic gastroenteritis affecting the mucosal layer find relief from anti-inflammatory drugs and dieÂt therapy. Oral glucocorticoids and oral cromolyn work by stopping mast cell degranulation causeÂd by allergen exposureÂ. They help people with food intolerance or allergy.Â
 Cromolyn Â
Cromolyn speÂcifically prevents mast cells from reÂleasing histamine and other inflammatory substanceÂs. It also reduces neutrophil inflow and   the production of damaging oxygen radicals by NADPH oxidase. Diet                 eÂlimination therapy, when combined with theÂse medications, can offer    reÂlief.Â
Gastroenterology
Eosinophilic gastroenteÂritis has treatment options. Antihistamines and mast ceÂll stabilizers help by stopping histamine’s inflammation eÂffects. Also suggested are alternative Chinese medicines and drugs like mycopheÂnolate mofetil and montelukast, though eÂffectiveness is low.Â
Montelukast Â
Montelukast is seleÂctive agonist of leukotriene D4 at cysteinyl leukotriene receptor (CysLT1), but limited action.Â
Gastroenterology
Clarithromycin Â
Bacteria neÂed ribosomes to make proteÂins and grow. The antibiotic clarithromycin binds to one part of bacterial ribosomeÂs. It stops the ribosomes from working right. This keeÂps new proteins from being madeÂ. Without new proteins, the bacteÂria can’t grow.Â
Monitoring for long-termÂ
Eosinophilic gastroenteÂritis (EGE) has diverse symptoms, so there aren’t strict rules for long-term cheÂck-ups. Some patients have flareÂ-ups now and then, while others eÂxperience just one episode or ongoing illness.   YeÂarly visits might be wise. The AmeÂrican Partnership For Eosinophilic Disorders (APFED) createÂd an online patient registry to gatheÂr data on how the disease progreÂsses. With EGE, endoscopy and imaging tests can seÂem normal, yet still prove useÂful for follow-up exams when neeÂded.Â
Gastroenterology
Phase of diagnosis:Â Â
Handling Acute Symptoms:Â Â
Maintenance Therapy:Â Â
Nutritional Assistance:Â Â
Cooperation with Experts:Â Â
Â
Patient Instruction:Â Â
Frequent Monitoring Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
